Cryo Cell International (CCEL) Accounts Payables (2010 - 2026)

Cryo Cell International has disclosed Accounts Payables across 17 years of filings, most recently posting $3.3 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 20.3% year-over-year to $3.3 million; the TTM figure through Feb 2026 stood at $3.3 million (up 20.3% YoY), while the FY2025 annual figure was $2.9 million, up 52.52% from the prior year.
• Accounts Payables advanced to $3.3 million in Q1 2026, from $2.9 million in the prior quarter.
• Over the last five years, Accounts Payables for CCEL reached as high as $4.1 million in Q2 2023 and fell as low as $491920.0 in Q4 2023.
• The 5-year median for Accounts Payables is $2.2 million (2025), against an average of $2.3 million.
• Annual changes were most pronounced in 2023 — Accounts Payables sank 69.36% — and 2024, when it soared 282.64%.
• A 5-year view of Accounts Payables shows it stood at $1.6 million in 2022, then slumped by 69.36% to $491920.0 in 2023, then soared by 282.64% to $1.9 million in 2024, then surged by 52.52% to $2.9 million in 2025, then increased by 15.0% to $3.3 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.3 million, $2.9 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.